IRCT20200509047364N2招募中3 期
The effect of Famotidine on the improvement of patients with COVID-19
Bandare-abbas University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All COVID-19 patients whose disease has been confirmed by the PCR test for SARS-Cov-2.
- •Signing the written consent of the study participant.
排除标准
- •All Immunocompromised patients
- •End stage renal disease
- •Moderate renal insufficiency (creatinine clearance 30-50 mL/min)
- •stage 4 sever chronic kidney disease
- •requiring dialysis (i.e creatinine clearance <30 mL/min)
- •History of hepatic disease
- •History of hepatitis C infection
- •History of alcoholism
- •G-6-PD (glucose-6-phosphate dehydrogenase deficiency)
- •ALT/AST >5 times the upper limit of normal.
- •History of or evidence of QT prolongation on ECG examination
- •History of psoriasis
- •History of porphyria
- •Use of oral contraceptive pills (OCP)
- •Concomitant use of Dasatinib
- •Concomitant use of Neratinib
- •Concomitant use of Ozanimod
- •Concomitant use of Pazopanib
- •Concomitant use of Rilpivirine
- •Concomitant use of Siponimod
- •Concomitant use of Tizanidine
- •Allergy to any study medication
研究者
相似试验
招募中
3 期
The effect of famotidine on reducing the side effects of prostate cancer radiotherapyIRCT20231121060132N1Kermanshah University of Medical Sciences50
招募中
Unknown
Bioequivalence study of Famotidine SuspensioIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N44Tabriz University of Medical Sciences24
进行中（未招募）
1 期
FAMODREP : Interest of Famotidine in Reducing Endothelial Expression of P-selectin in Children With Sickle Cell Disease: Pilot Study, Single-center, Prospective, Non-comparativeSickle Cell DiseaseCTIS2022-502144-12-00Assistance Publique Hopitaux De Paris30
尚未招募
2 期
Famotidine for the improvement of cognitive impairments in COVID-19 patientsCOVID-19.COVID-19, virus identifiedU07.1IRCT20090117001556N138Tehran University of Medical Sciences50
已完成
1 期
Evaluation of the Radioprotective Effect of Famotidine Against Radiotherapy- induced Acute Toxicity in Patients with Prostate CancerBowel toxicityUrinary toxicityCancer - ProstateOral and Gastrointestinal - Normal oral and gastrointestinal development and functionRenal and Urogenital - Normal development and function of male and female renal and urogenital systemProstate CancerACTRN12612000101886School of Paramedical Sciences, Shahid Beheshti Medical University,36